Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised, Double-Blind, Placebo-Controlled Trial of Phenserine Tartrate in Alzheimer's Disease
2004-001187-52Phase 2Completed
- Sponsor
- Axonyx
- Start
- Nov 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of phenserine in Alzheimer's disease (AD) (3 arms), sponsored by Axonyx. Primary endpoints: Cognitive performance (ADAS-cog) and Global clinical impression of therapeutic effect (CIBIC+). Started Nov 2004; status: completed.
02
Drugs
phenserine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2004-001187-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001187-52.